Learn More


 
MBA Tools
MBA Glossary

 


SPDR S&P Pharmaceuticals (ETF) - XPH - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

 

SPDR S&P Pharmaceuticals (ETF) - SIC # 6722

Ticker Exchange SIC # Website Latest Ticker
XPH New York 6722 https://www.spdrs.com/ 72.23 Stock Up +0.26

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for SPDR S&P Pharmaceuticals (ETF)

ETFs For The 'Third Scenario' - Jun 18th, 2013 1:00 am
Friday's ETF with Unusual Volume: XPH - Jun 14th, 2013 11:58 am
Thursday's ETF with Unusual Volume: XPH - May 9th, 2013 11:59 am
The Best Pharmaceutical Investments - Mar 20th, 2013 1:01 pm
3 ETFs In Case Of A Market Correction - Mar 19th, 2013 11:59 am
Are You Prepared For a Market Drop? - Mar 12th, 2013 9:00 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter